Sortina Pharma is one of six Swedish biopharma companies presenting at “Innovation begins with unanswered questions”, a life science evening organised by the Swedish Swiss Chamber of Commerce (SSCC) and hosted by Implement Consulting Group in Zurich on 29 October 2026.
The event showcases early- and clinical-stage companies working on unmet medical needs. It features a keynote by Professor Carlos Cordon of IMD and a Q&A moderated by Meng Tian of Simature. We present our work on small-molecule sortilin inhibitors and look forward to meeting investors, industry representatives and fellow founders during the networking session.
Read more about the event here